Literature DB >> 21625088

The quest to standardize hemodialysis care.

Jörgen Hegbrant, Giorgio Gentile, Giovanni F M Strippoli.   

Abstract

A large global dialysis provider's core activities include providing dialysis care with excellent quality, ensuring a low variability across the clinic network and ensuring strong focus on patient safety. In this article, we summarize the pertinent components of the quality assurance and safety program of the Diaverum Renal Services Group. Concerning medical performance, the key components of a successful quality program are setting treatment targets; implementing evidence-based guidelines and clinical protocols; consistently, regularly, prospectively and accurately collecting data from all clinics in the network; processing collected data to provide feedback to clinics in a timely manner, incorporating information on interclinic and intercountry variations; and revising targets, guidelines and clinical protocols based on sound scientific data. The key activities for ensuring patient safety include a standardized approach to education, i.e. a uniform education program including control of theoretical knowledge and clinical competencies; implementation of clinical policies and procedures in the organization in order to reduce variability and potential defects in clinic practice; and auditing of clinical practice on a regular basis. By applying a standardized and systematic continuous quality improvement approach throughout the entire organization, it has been possible for Diaverum to progressively improve medical performance and ensure patient safety.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21625088     DOI: 10.1159/000327338

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  1 in total

1.  Predicting the Appearance of Hypotension During Hemodialysis Sessions Using Machine Learning Classifiers.

Authors:  Juan A Gómez-Pulido; José M Gómez-Pulido; Diego Rodríguez-Puyol; María-Luz Polo-Luque; Miguel Vargas-Lombardo
Journal:  Int J Environ Res Public Health       Date:  2021-02-28       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.